Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Pacific Biosciences of California, Inc. (PACB) stock profile

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyze biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflows, such as template preparation kits to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprising reagents required for on-instrument, real-time sequencing, including phospholinked nucleotides. The company serves research institutions, commercial laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions, pharmaceutical companies, and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. It was incorporated in 2000 and is headquartered in Menlo Park, California.

Key facts

SymbolPACB
ExchangeNASDAQ
SectorHealthcare
IndustryMedical - Devices
CEOChristian O. Henry
Employees575
HeadquartersMenlo Park, CA, US
IPO2010-10-27
Websitewww.pacb.com

Explore PACB on Vantafin

  • Pacific Biosciences of California, Inc. Overview
  • Pacific Biosciences of California, Inc. Financials
  • Pacific Biosciences of California, Inc. News
  • Pacific Biosciences of California, Inc. Events
  • Pacific Biosciences of California, Inc. SEC filings
  • Pacific Biosciences of California, Inc. Insider transactions
  • Pacific Biosciences of California, Inc. Transcripts

Frequently asked questions

What does Pacific Biosciences of California, Inc. (PACB) do?
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyze biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflows, such as template preparation kits to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprising reagents required for on-instrument, real-time sequencing, including phospholinked nucleotides. The company serves research institutions, commercial laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions, pharmaceutical companies, and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. It was incorporated in 2000 and is headquartered in Menlo Park, California.
Where is PACB stock listed?
Pacific Biosciences of California, Inc. trades under the ticker PACB on NASDAQ.
How can I research PACB's financials and filings?
Vantafin provides Pacific Biosciences of California, Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the PACB profile.